Literature DB >> 20359285

Comparison of enzyme kinetic parameters obtained in vitro for reactions mediated by human CYP2C enzymes including major CYP2C9 variants.

D Rokitta1, U Fuhr.   

Abstract

Cytochrome P450 (CYP) 2C enzymes contribute to the metabolism of about 30% of all drugs. Known polymorphisms of the respective enzymes and drug-drug interactions have a major impact on the efficacy and safety of some CYP2C substrate drugs. In vivo - in vitro correlations including prediction of the effect of such covariates requires quantitative information on enzyme kinetics. In this article there will be a summary of the values of the Michaelis-Menten constant (K(m)), the maximal velocity (V(max)) and the intrinsic clearance (Cl(int); V(max)/K(m)) for 84 substrates (100 reactions) reported to be mediated by CYP2C9 (variant enzymes CYP2C9.1, CYP2C9.2 and CYP2C9.3), CYP2C8 and/or CYP2C19. Particularly contradictory findings for the same reactions call for some standardization in the assessment of enzyme kinetics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359285     DOI: 10.2174/138920010791110872

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  5 in total

1.  Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphism.

Authors:  Y Liu; H Jeong; H Takahashi; K Drozda; S R Patel; N L Shapiro; E A Nutescu; L H Cavallari
Journal:  Clin Pharmacol Ther       Date:  2012-02-29       Impact factor: 6.875

2.  The limits of genome-wide methods for pharmacogenomic testing.

Authors:  Eric R Gamazon; Andrew D Skol; Minoli A Perera
Journal:  Pharmacogenet Genomics       Date:  2012-04       Impact factor: 2.089

3.  Predicting CYP2C19 catalytic parameters for enantioselective oxidations using artificial neural networks and a chirality code.

Authors:  Jessica H Hartman; Steven D Cothren; Sun-Ha Park; Chul-Ho Yun; Jerry A Darsey; Grover P Miller
Journal:  Bioorg Med Chem       Date:  2013-04-22       Impact factor: 3.641

4.  Inhibition of human cytochrome P450 enzymes by hops (Humulus lupulus) and hop prenylphenols.

Authors:  Yang Yuan; Xi Qiu; Dejan Nikolić; Shao-Nong Chen; Ke Huang; Guannan Li; Guido F Pauli; Richard B van Breemen
Journal:  Eur J Pharm Sci       Date:  2013-12-14       Impact factor: 4.384

5.  CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.

Authors:  Elizabeth L Barry; Elizabeth M Poole; John A Baron; Karen W Makar; Leila A Mott; Robert S Sandler; Dennis J Ahnen; Robert S Bresalier; Gail E McKeown-Eyssen; Cornelia M Ulrich
Journal:  Cancer Causes Control       Date:  2012-10-19       Impact factor: 2.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.